S-Space College of Medicine/School of Medicine (의과대학/대학원) Internal Medicine (내과학전공) Journal Papers (저널논문_내과학전공)
Risk Stratification of Distant Metastasis in Patients Undergoing Adjuvant Chemoradiation for Extrahepatic Bile Duct Cancer
- Issue Date
- ELSEVIER SCIENCE INC
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS; Vol.78 3; S294-S295
- Purpose/Objective(s): To analyze the prognostic factors predicting treatment outcome in patients undergoing adjuvant chemoradiation
for extrahepatic bile duct cancer.
Materials/Methods: Between January 1991 and August 2006, 166 patients with extrahepatic bile duct cancer underwent curative
resection followed by adjuvant chemoradiation. There were 120 males and 46 females, and median age was 61 years (range; 34-
86). Postoperative radiotherapy was delivered to tumor bed and regional lymph nodes up to 40-56 Gy. One hundred and fifty-seven
patients also received intravenous 5-fluorouracil or oral capecitabine as a radiosensitizer, and 5-fluorouracil-based maintenance
chemotherapy was administered to 132 patients. Median follow-up duration was 29 months.
Results: The 5-year loco-regional relapse-free, distant metastasis-free, and overall survival rate was 63.5%, 49.4%, and 42.5%,
respectively. Major pattern of failure was distant metastasis. There were 51 patients with isolated distant metastases, 21 with isolated
loco-regional recurrences, and 25 with combined loco-regional and distant relapses. The most common site of distant failure
was the liver (n = 36). On multivariate analysis, hilar tumor, tumor size $2 cm, involved lymph node, and poorly differentiated
tumor were associated with inferior distant metastasis-free survival (p = 0.0063, 0.0349, 0.0011, and 0.0184, respectively), whereas
patients age, involved resection margin, T stage, and perineural invasion were not (p = 0.5930, 0.2491, 0.7665, and 0.2168, respectively).
When patients were divided into four groups based on these risk factors, the 5-year distant metastasis-free survival rates
for patients with 0, 1, 2, and 3 risk factors were 86.4%, 57.0%, 31.8%, and 0%, respectively (p\0.0001).
Conclusions: Despite the maintenance chemotherapy, distant metastasis was the major pattern of failure in patients undergoing
adjuvant chemoradiation for extrahepatic bile duct cancer. More intensified chemotherapy is warranted to improve the treatment
outcome of resected extrahepatic bile duct cancer, especially in those with risk factors such as hilar location, larger tumor size,
involved lymph node, and/or poorly differentiated histology.
- Files in This Item: There are no files associated with this item.